Track the latest insights on paracetamol price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Get real-time access to monthly/quarterly/yearly prices Request Sample
During the third quarter of 2025, the paracetamol prices in the USA reached 3573 USD/MT in September. Prices decreased as purchasing slowed across formulation plants adjusting to shifts in over-the-counter consumption patterns. Suppliers aligned operating schedules with feedstock availability, while distributors managed rising transport premiums across major interstate corridors. These conditions influenced how buyers structured delivery cycles within the domestic market.
During the third quarter of 2025, the paracetamol prices in China reached 3415 USD/MT in September. Market values eased as procurement became more deliberate among bulk pharmaceutical manufacturers. Producers adjusted processing intensity in response to controlled inventories, and exporters navigated varied container availability across major coastal terminals. Regional transport planning also shifted due to route-specific congestion tied to internal freight hubs.
During the third quarter of 2025, the paracetamol prices in Germany reached 3496 USD/MT in September. Values eased as buyers moderated purchasing in response to stable but measured formulation activity. Import-oriented procurement involved navigating documentation standards that varied across European suppliers. Inland transport demand on key German corridors influenced shipment timing for bulk distributors.
During the third quarter of 2025, the paracetamol prices in India reached 2911 USD/MT in September. Prices edged down as formulation units operated with calibrated raw-material intake. Producers balanced run rates with intermediate availability, and domestic transport networks faced seasonal variability that shaped timing for bulk deliveries. Buyers also coordinated replenishment cycles around fluctuating warehouse capacity across major industrial zones.
During the third quarter of 2025, the paracetamol prices in France reached 3787 USD/MT in September. Market levels moved lower as pharmaceutical processors moderated purchasing volumes. Import workflows across western and southern ports followed differing clearance routines, prompting buyers to stagger shipments. Inland distribution choices were also shaped by regulatory requirements linked to traceability within the French pharmaceutical supply chain.
During the second quarter of 2025, the paracetamol prices in the USA reached 3821 USD/MT in June. In the USA, paracetamol prices in Q2 2025 were influenced by rising demand from the over-the-counter medicine segment due to seasonal consumption trends. Import dependency on Asian suppliers created vulnerabilities amid extended shipping lead times and higher ocean freight costs. Additionally, regulatory reviews on pharmaceutical ingredients and limited local active pharmaceutical ingredient (API) production added supply-side constraints for domestic formulators.
During the second quarter of 2025, paracetamol prices in China reached 3732 USD/MT in June. In China, paracetamol pricing was impacted by elevated raw material costs, particularly for para-aminophenol, as well as stricter environmental compliance requirements for chemical manufacturing units. The quarter also saw scheduled maintenance activities at key API production facilities, leading to temporary capacity reductions. Growing domestic demand from the healthcare and export formulation sectors further tightened inventory levels available for the bulk drug market.
During the second quarter of 2025, the paracetamol prices in Germany reached 3767 USD/MT in June. In Germany, paracetamol prices were affected by steady demand from the pharmaceutical and hospital procurement sectors. Challenges in securing timely API shipments from India and China, compounded by European port delays and container shortages, impacted formulation schedules. Regulatory lead times for raw material certification and limited spot availability from regional distributors added procurement uncertainty across pharmaceutical supply chains.
During the second quarter of 2025, the paracetamol prices in India reached 2958 USD/MT in June. In India, pricing dynamics for paracetamol were driven by fluctuating input costs for key intermediates and variable demand from both domestic and export-oriented formulation units. Temporary disruptions at chemical manufacturing clusters due to environmental audits reduced production efficiency. Additionally, currency volatility affected import costs for upstream chemicals not locally sourced, while high inventory turnover among generic drug producers influenced procurement cycles.
During the second quarter of 2025, the paracetamol prices in France reached 3965 USD/MT in June. In France, paracetamol pricing trends were influenced by consistent consumption from the public healthcare sector and pharmacies. Import delays of key APIs from Asia, especially China, disrupted formulation timelines for contract manufacturers. Local production was constrained by limited surplus capacity and longer quality assurance cycles. Rising packaging and energy costs during the quarter also exerted upward pressure on finished product costs.

The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the paracetamol prices.
Q3 2025:
As per the paracetamol price index, European prices trended downward as pharmaceutical manufacturers adopted more measured procurement across major production hubs. Northern European processing sites synchronized operating rhythms with compliance-driven adjustments, while Southern European importers balanced shipments across short-sea routes with varied port efficiency. Differences in supplier qualification procedures across EU markets shaped sourcing decisions. Rail and road availability also shifted across regional corridors, guiding how distributors organized deliveries within the continent.
Q2 2025:
As per the paracetamol price index, European paracetamol prices in Q2 2025 were influenced by consistent demand from the pharmaceutical, hospital, and consumer healthcare sectors. Supply chain disruptions stemming from delayed API shipments from Asia and ongoing logistics bottlenecks across key European ports created procurement uncertainty. Additionally, rising energy and compliance costs for local drug manufacturers and a limited number of EU-based API producers contributed to tighter market conditions for formulators and distributors.
This analysis can be extended to include detailed paracetamol price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
Q3 2025:
As per the paracetamol price index, North American prices moved lower as healthcare distributors fine-tuned purchasing to reflect moderate demand in both prescription and OTC channels. Gulf Coast facilities managed berth allocations amid overlapping pharmaceutical ingredient movements, while Midwest hubs encountered irregular trucking capacity tied to labor rotation cycles. Canadian buyers navigated compliance checks at border points, affecting scheduling for inbound material. Storage constraints in several inland centers shaped inventory timing across the region.
Q2 2025:
As per the paracetamol price index, in North America, paracetamol pricing was shaped by steady over-the-counter (OTC) medicine demand, combined with continued reliance on imported APIs, primarily from China and India. Prolonged ocean transit times, higher freight charges, and stricter regulatory scrutiny on imported pharmaceutical ingredients influenced inventory planning. Moreover, limited domestic API manufacturing capacity and increased safety stock procurement by major drug retailers impacted sourcing dynamics across both the USA and Canada.
Specific paracetamol historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Q3 2025:
As per paracetamol price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
Q2 2025:
The report explores the paracetamol pricing trends and paracetamol price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on paracetamol prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Q3 2025:
Asia Pacific prices declined as major formulation centers in China and India moderated intake to align with steady but cautious production targets. Chinese producers adapted operating rates to variable feedstock conditions, while Indian transport networks faced seasonal routing shifts that influenced delivery timing. Import-reliant countries navigated container realignments in trans-shipment hubs, prompting diversified sourcing choices. Seasonal disruptions in Southeast Asian road networks also shaped procurement planning.
Q2 2025:
In the Asia Pacific region, paracetamol prices were driven by shifts in upstream raw material costs, particularly for para-aminophenol, and strong regional demand from formulation and export units. In China and India, environmental inspections and plant maintenance cycles affected API output. Meanwhile, pharmaceutical consumption trends in Southeast Asia and fluctuations in chemical input availability influenced intra-regional trade flows and procurement volumes for contract manufacturers.
This paracetamol price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Q3 2025:
Latin America's paracetamol market is predominantly influenced by its rich natural reserves, particularly in countries like Chile and Brazil. However, political instability and inconsistent regulatory frameworks can lead to significant volatility in paracetamol prices.
Q2 2025:
Infrastructure challenges and logistical inefficiencies often impact the supply chain, affecting Latin America’s ability to meet international demand consistently. Moreover, the paracetamol price index, economic fluctuations, and currency devaluation are critical factors that need to be considered when analyzing paracetamol pricing trends in this region.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
IMARC's latest publication, “Paracetamol Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the paracetamol market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of paracetamol at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed paracetamol prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting paracetamol pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

The global paracetamol industry size reached USD 809.97 Million in 2025. By 2034, IMARC Group expects the market to reach USD 1,141.00 Million, at a projected CAGR of 3.88% during 2026-2034. Growth is supported by consistent pharmaceutical consumption, the rising preference for analgesics, continuous formulation activities across developing and developed markets, and stable supply chain structures that align with the observed directional pricing movements across recent quarters.
Latest developments in the paracetamol industry:
Paracetamol, commonly known as acetaminophen in some regions, is one of the most extensively employed medicine, that is popular for its analgesic, i.e., pain-relieving and antipyretic or fever-reducing qualities. It belongs to the class of drugs called analgesics and is generally used to treat mild to moderate pain as well as fever. Paracetamol works by blocking the generation of certain brain chemicals that transmit pain signals and control body temperature.
This medication is marketed in an array of forms, including tablets, capsules, syrups, and effervescent powders, making it easy to use orally. It is frequently used to treat headaches, toothaches, muscular pains, arthritis, and fever caused by colds and flu. Paracetamol is regarded as a relatively safe medication when taken in accordance with approved dosages. However, exceeding the recommended amount can harm liver, making it crucial to follow prescribed guidelines and parameters. Paracetamol is widely available for self-medication since it is frequently found as an active component in several OTC cold and flu drugs. It is a staple in cabinets throughout the world, providing millions of people relief from pain and fever, every day.
| Key Attributes | Details |
|---|---|
| Product Name | Paracetamol |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Paracetamol Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand* Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.